Monograph Details
|
|
Respiratory Tract
> Asthma/COPD
|
|
ACCUNEB |
| Manufacturer |
|
DEY Pharma |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
β2-agonist. |
| Generic Name |
|
Albuterol (as sulfate) 0.63mg/3mL (0.021%), 1.25mg/3mL (0.042%); soln for inh; preservative-free. |
| Indications |
|
Bronchospasm. |
| Children |
|
<2yrs: not recommended. ≥2yrs: 1 vial by nebulizer 3–4 times daily over 5–15 minutes. |
| Adults |
|
Not recommended. |
| Precautions |
|
Avoid excessive use. Sensitivity to sympathomimetics. Consider higher dose albuterol product in acute attack. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disease (eg, coronary insufficiency, arrhythmias, hypertension). Diabetes. Hyperthyroidism. Seizure disorders. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Avoid MAOIs, tricyclics within 14 days (increased cardiovascular effects). Other short-acting sympathomimetics: not recommended. Antagonized by β-blockers. Monitor digoxin. Caution with other drugs that lower serum potassium (eg, diuretics). |
| Adverse Reactions |
|
Tremor, nervousness, headache, dizziness, hyperactivity, insomnia, weakness, tachycardia, epistaxis, hypokalemia, local irritation (inh), paradoxical bronchospasm, rash. |
| How Supplied |
|
Vials (3mL)—25 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
